Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 11:9:672260.
doi: 10.3389/fped.2021.672260. eCollection 2021.

Case Series: Efficacy and Safety of Hemoadsorption With HA-330 Adsorber in Septic Pediatric Patients With Cancer

Vitaliy Sazonov  1   2 , Ramazan Abylkassov  2   3 , Zaure Tobylbayeva  2 , Askhat Saparov  2 , Olga Mironova  2 , Dimitri Poddighe  3   4
Affiliations
Case Reports

Case Series: Efficacy and Safety of Hemoadsorption With HA-330 Adsorber in Septic Pediatric Patients With Cancer

Vitaliy Sazonov et al. Front Pediatr. .

Abstract

Background: Sepsis is a frequent cause of death in hospitalized patients and, in detail, in neonatal, pediatric, and adult intensive care units (ICUs). Severe sepsis has a very poor prognosis. Indeed, the mortality rate varies between 30 and 70% during the first 7-14 days. Despite a timely and appropriate therapy, the prognosis of severe sepsis is too often negative. Therefore, new therapeutic resources are under investigation in order to further improve prognosis. Case series: Here, we reported three septic children in whom we used extracorporeal blood purification therapy with hemoadsorption device HA330 (Jafron Biomedical Co., Ltd., China), aiming to scavenge and eliminate bacterial toxins and inflammatory mediators from the blood. Discussion and Conclusion: This small case series first showed that hemoperfusion with HA330 cartridge may be an effective and relatively safe adjunctive treatment to counterbalance the cytokine storm in septic children with hematological disorders. Further studies are needed to confirm and further support its safety and efficacy in a large number of pediatric patients.

Keywords: HA-330 adsorber; blood purification; hemoadsorption; pediatric cancer; sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. (2020) 395:200–11. 10.1016/S0140-6736(19)32989-7 - DOI - PMC - PubMed
    1. Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. (2018) 6:223–30. 10.1016/S2213-2600(18)30063-8 - DOI - PubMed
    1. Matot I, Sprung CL. Definition of sepsis. Intens Care Med. (2001) 27(Suppl. 1):S3–9. 10.1007/PL00003795 - DOI - PubMed
    1. Studnek JR, Artho MR, Garner CL, Jr, Jones AE. The impact of emergency medical services on the ED care of severe sepsis. Am J Emerg Med. (2012) 30:51–6. 10.1016/j.ajem.2010.09.015 - DOI - PMC - PubMed
    1. Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis . International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. (2005) 6:2–8. 10.1097/00130478-200501000-00049 - DOI - PubMed

Publication types

LinkOut - more resources